Infiltration Of Tumor By T Cells Following Treatment With Dpx-Survivac And Intermittent Low Dose Cyclophosphamide (Cpa) Leads To Clinical Responses In Advanced Recurrent Ovarian Cancer (Ovca).

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览14
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要